Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study

Objectives Pulmonary vein isolation (PVI) is widely accepted as an effective and safe treatment for symptomatic atrial fibrillation (AF). However, data on sex-related differences and associations with clinical outcome and safety of PVI with cryoballoon ablation are limited. We sought to compare sexr...

Full description

Bibliographic Details
Main Authors: Michiel Rienstra, Robert G Tieleman, Isabelle C van Gelder, Bart A Mulder, Yuri Blaauw, Eng S Tan, Federico T Magni, Hessel F Groenveld, Neda Khalilian Ekrami, Vijay Dayalani, Ans CP Wiesfeld
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/11/e063359.full
_version_ 1811180249142001664
author Michiel Rienstra
Robert G Tieleman
Isabelle C van Gelder
Bart A Mulder
Yuri Blaauw
Eng S Tan
Federico T Magni
Hessel F Groenveld
Neda Khalilian Ekrami
Vijay Dayalani
Ans CP Wiesfeld
author_facet Michiel Rienstra
Robert G Tieleman
Isabelle C van Gelder
Bart A Mulder
Yuri Blaauw
Eng S Tan
Federico T Magni
Hessel F Groenveld
Neda Khalilian Ekrami
Vijay Dayalani
Ans CP Wiesfeld
author_sort Michiel Rienstra
collection DOAJ
description Objectives Pulmonary vein isolation (PVI) is widely accepted as an effective and safe treatment for symptomatic atrial fibrillation (AF). However, data on sex-related differences and associations with clinical outcome and safety of PVI with cryoballoon ablation are limited. We sought to compare sexrelated efficacy and safety of cryoballoon ablation and identify sex-related associations with clinical outcomes.Methods and results We included 650 consecutive patients with AF undergoing PVI with cryoballoon ablation at our institution between 2013 and 2017. The efficacy outcome was the first documented recurrence (>30 s) of AF, atrial flutter or atrial tachycardia (AF/AT) or repeat ablation during follow-up, after a 90-day blanking period. The safety outcome was the incidence of periprocedural complications. Mean age of the population was 58±10, and 210 (32.3%) patients were women. Women were older, had a higher body mass index, had more renal dysfunction and less coronary artery disease as compared with men. The rate of AF/AT recurrence was similar between women and men at 12-month follow-up (27.6% vs 24.8%, p=0.445). The incidence of periprocedural complications was higher in women (12.9% vs 4.6%; p<0.001), specifically groin haematomas and phrenic nerve palsy. On multivariate analysis, left atrial volume index (adjusted OR 1.05, 95% CI 1.00 to 1.10; p=0.032) was associated with the incidence of procedural complications in women. For men, no relation with complications could be found.Conclusion The efficacy of cryoballoon ablation was similar between women and men; however, women had a higher risk of procedural complications.
first_indexed 2024-04-11T06:48:09Z
format Article
id doaj.art-9a2d71bec5b0462b8446c07d68321861
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-04-11T06:48:09Z
publishDate 2022-11-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-9a2d71bec5b0462b8446c07d683218612022-12-22T04:39:18ZengBMJ Publishing GroupBMJ Open2044-60552022-11-01121110.1136/bmjopen-2022-063359Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort studyMichiel Rienstra0Robert G Tieleman1Isabelle C van Gelder2Bart A Mulder3Yuri Blaauw4Eng S Tan5Federico T Magni6Hessel F Groenveld7Neda Khalilian Ekrami8Vijay Dayalani9Ans CP Wiesfeld10Department of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsDepartment of Cardiology, Univeristy Medical Center Groningen, Groningen, The NetherlandsObjectives Pulmonary vein isolation (PVI) is widely accepted as an effective and safe treatment for symptomatic atrial fibrillation (AF). However, data on sex-related differences and associations with clinical outcome and safety of PVI with cryoballoon ablation are limited. We sought to compare sexrelated efficacy and safety of cryoballoon ablation and identify sex-related associations with clinical outcomes.Methods and results We included 650 consecutive patients with AF undergoing PVI with cryoballoon ablation at our institution between 2013 and 2017. The efficacy outcome was the first documented recurrence (>30 s) of AF, atrial flutter or atrial tachycardia (AF/AT) or repeat ablation during follow-up, after a 90-day blanking period. The safety outcome was the incidence of periprocedural complications. Mean age of the population was 58±10, and 210 (32.3%) patients were women. Women were older, had a higher body mass index, had more renal dysfunction and less coronary artery disease as compared with men. The rate of AF/AT recurrence was similar between women and men at 12-month follow-up (27.6% vs 24.8%, p=0.445). The incidence of periprocedural complications was higher in women (12.9% vs 4.6%; p<0.001), specifically groin haematomas and phrenic nerve palsy. On multivariate analysis, left atrial volume index (adjusted OR 1.05, 95% CI 1.00 to 1.10; p=0.032) was associated with the incidence of procedural complications in women. For men, no relation with complications could be found.Conclusion The efficacy of cryoballoon ablation was similar between women and men; however, women had a higher risk of procedural complications.https://bmjopen.bmj.com/content/12/11/e063359.full
spellingShingle Michiel Rienstra
Robert G Tieleman
Isabelle C van Gelder
Bart A Mulder
Yuri Blaauw
Eng S Tan
Federico T Magni
Hessel F Groenveld
Neda Khalilian Ekrami
Vijay Dayalani
Ans CP Wiesfeld
Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
BMJ Open
title Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
title_full Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
title_fullStr Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
title_full_unstemmed Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
title_short Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
title_sort assessment of sex related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation an observational cohort study
url https://bmjopen.bmj.com/content/12/11/e063359.full
work_keys_str_mv AT michielrienstra assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT robertgtieleman assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT isabellecvangelder assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT bartamulder assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT yuriblaauw assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT engstan assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT federicotmagni assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT hesselfgroenveld assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT nedakhalilianekrami assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT vijaydayalani assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy
AT anscpwiesfeld assessmentofsexrelateddifferencesandoutcomeinpatientswhounderwentcryoballoonpulmonaryveinisolationforatrialfibrillationanobservationalcohortstudy